Welcome to NewSpring Health Capital

NewSpring Health Capital provides equity capital to healthcare companies within the life science, healthcare services and medical devices sectors. The Fund focuses its investments in growing sectors of the health care and pharmaceutical industries, which include:

Biopharmaceuticals: Companies developing biopharmaceutical products or technologies, emphasizing the therapeutic areas of the central nervous system (CNS), cancer and oncology, and endocrine and metabolic disorders, among others.

Medical devices: Companies developing innovative medical devices, diagnostics, or drug delivery platforms.

Health care services: Companies offering novel health care services that generate revenue by executing cost-effective business models, including pharmaceutical distribution, outpatient and inpatient specialty services, health administration outsourcing, benefits and insurance management and health care informatics, among others.

NewSpring Health Capital emphasizes firms in the Mid-Atlantic region and Northeast corridor – a region rich in emerging biopharmaceutical, medical device, and health care service companies. This region is home to a quarter of the U.S. population; ranked third in university science and research and development expenditures; ranked second for patent production; and ranked fourth for the total number of biotechnology scientists. Such factors create compelling opportunities for entrepreneurs, managers, operators, and investors in emerging health care and life sciences companies in the Mid-Atlantic region.